封面
市場調查報告書
商品編碼
1627660

筆針市場:預測(2025-2030)

Pen Needle Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計在預測期內,筆用針頭市場將以 9.27% 的複合年成長率成長,市場規模從 2025 年的 2,046,792,000 美元增至 2030 年的 3,189,012,000 美元。

筆式針頭廣泛用於將注射藥物注射到體內。慢性病盛行率上升預計將成為預測期內市場成長的主要驅動力之一。然而,替代品的供應預計將限制未來幾年的市場成長。

筆針市場促進因素

  • 預計各種慢性病盛行率的增加將在預測期內推動市場發展。

癌症和糖尿病等慢性病盛行率的增加是預測期內市場成長的主要驅動力之一。根據國際糖尿病聯盟的報告,20歲至79歲的糖尿病患者人數將從2017年的4.25億增加到2022年的5.37億,到2045年將增加到7.83億。

此外,糖尿病日益增加的經濟負擔和全球醫療保健支出的增加預計也將增加未來幾年對血糖監測快速診斷試劑套件的需求。根據國際糖尿病聯盟(IDF)預測,2022年全球糖尿病醫療費用將約為9,660億美元,較過去15年成長316%。

根據世界衛生組織(WHO)預測,2022年將有近130萬人死於慢性B型肝炎和C型肝炎感染,其中約2.54億人將死於B型肝炎,5,000萬人死於C型肝炎感染。世界衛生組織在報告中稱,2010年,估計有5.24億人年齡在65歲及以上,佔世界人口的8%,但到2050年,這一數字將幾乎增加兩倍,預計這一數字將達到約15億。

營養不良、缺乏運動和有害飲酒會導致心血管疾病、癌症和慢性呼吸道疾病等慢性疾病的發生,似乎將直接影響未來幾年的筆用針頭市場。

北美佔據主要市場佔有率:

按地區分類,筆針市場分為北美、南美、歐洲、中東和非洲以及亞太地區。由於慢性疾病患者數量的增加,佩恩針在北美迅速流行。根據疾病管制與預防中心的數據,美國有 608,336 人死於癌症。對最大限度減少副作用的藥物輸送系統的需求迅速成長,推動了該國對筆用針頭的需求。

技術的進步和醫療保健成本的上升極大地推動了筆針市場的成長。例如,根據美國醫療保險和醫療補助服務中心的數據,2022 年美國醫療保健支出成長 4.1%,達到 4.5 兆美元。

在歐洲,各國政府正在放鬆監管並加速創新新藥的核准流程,以滿足人口老化日益成長的需求。該舉措旨在促進國內和國際製藥公司的發展,並吸引新業務進入歐洲市場。

此外,國內市場參與者以併購形式增加的策略投資預計將加劇競爭,預計將進一步推動未來幾年的市場成長機會。

此外,在亞太地區,人口健康意識的提高以及新型注射給藥系統和技術使用市場的快速發展預計將在預測期內推動市場成長。中國和印度政府正在推出新政策來改善公民健康,包括擴大公立醫療機構的保險覆蓋範圍和標準化服務。

為什麼要購買這份報告?

  • 富有洞察力的分析:獲得涵蓋關鍵和新興地區的深入市場洞察,重點關注客戶細分、政府政策和社會經濟因素、消費者偏好、行業和其他子區隔。
  • 競爭格局:了解世界主要企業採取的策略策略,並了解透過正確的策略滲透市場的潛力。
  • 市場趨勢和促進因素:探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議:利用洞察力做出策略決策,在動態環境中發現新的業務流和收益。
  • 受眾廣泛:對於新興企業、研究機構、顧問、中小企業和大型企業有用且具有成本效益。

它有什麼用?

產業和市場考慮因素、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範和影響、新產品開發和競爭影響。

調查範圍

  • 2022年至2030年實際資料和預測
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 區域收益成長和預測分析,包括細分市場和國家
  • 公司概況(策略、產品、財務狀況、主要發展等)

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現
  • 分析師觀點

第4章市場動態

  • 市場促進因素
    • 包裝需求不斷成長
    • 永續性關注永續發展
  • 市場限制因素
    • 環境問題
    • 生產成本高
  • 波特五力分析
  • 產業價值鏈分析

第5章筆針市場分析:依類型

  • 介紹
  • 標準筆針
  • 安全筆針

第6章筆針市場分析:依長度

  • 介紹
  • 4毫米和5毫米
  • 6毫米和8毫米
  • 10毫米和12毫米

第7章筆針市場分析:依處理方式

  • 介紹
  • 胰島素
  • Glucagon-Like Peptide-1
  • 生長激素

第8章筆針市場分析:按分銷管道

  • 介紹
  • 線上
  • 離線

第9章筆針市場分析:按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 中東/非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 印尼
    • 泰國
    • 其他

第10章競爭環境及分析

  • 主要企業及策略分析
  • 新興企業和市場盈利
  • 合併、收購、協議和合作
  • 供應商競爭力矩陣

第11章 公司簡介

  • Becton, Dickinson and Company
  • Glucorx
  • Braun Melsungen
  • Ypsomed
  • Novo Nordisk
  • HTL-Strefa
  • Ultimed, Inc.
  • Allison Medical, Inc.
  • Terumo Corporation
  • Owen Mumford, Ltd.
簡介目錄
Product Code: KSI061613464

The pen needle market is expected to grow at a CAGR of 9.27% over the forecast period to reach a total market size of US$3,189.012 million by 2030, increasing from US$2,046.792 million in 2025.

Pen needles are widely used to deliver injectable medication into the body. The rising prevalence of chronic disease is expected to be one of the prime drivers of market growth during the forecast period. However, the availability of substitutes is anticipated to restrain the market's growth in the coming years.

Pen Needle Market Drivers

  • The growing prevalence of various chronic diseases is anticipated to drive the market in the forecasted period.

The rising prevalence of chronic diseases such as cancer and diabetes is one of the prime drivers for the market growth during the forecast period. According to the International Diabetes Federation report, the number of people with diabetes under the age group of 20-79 years has risen from 425 million in 2017 to 537 million in 2022 and is expected to reach 783 million in 2045.

In addition, the rising economic burden of diabetes and increasing healthcare expenditure worldwide are also anticipated to increase the demand for rapid diagnostic kits for glucose monitoring in the coming years. According to the International Diabetes Federation (IDF), global healthcare expenditure on diabetes was around USD 966 billion in 2022, representing an increase of 316% over the last 15 years.

According to the World Health Organization (WHO), in 2022, nearly 1.3 million people died from chronic hepatitis B and C infection, and approximately 254 million people lived with hepatitis B, and 50 million people are living with hepatitis C. The WHO, in its report, stated that in 2010, an estimated 524 million people were aged 65 or older, which constitutes 8 percent of the world's population, and by 2050 this number is expected to nearly triple to about 1.5 billion, representing 16% of the world population.

Poor nutrition, physical inactivity, and the harmful use of alcohol contribute to the development of chronic conditions like cardiovascular diseases, cancer, and chronic respiratory disease, which will directly affect the market for pen needles in the coming years.

North America holds a significant share of the market:

By geography, the pen needle market is segmented into North America, South America, Europe, the Middle East, Africa, and the Asia Pacific. The pen needle is fast gaining traction in North America due to the growing number of chronic disease cases. According to the United States Centre for Disease Control and Prevention, 6,08,336 people died due to cancer in the United States. The burgeoning need for a targeted drug delivery system that causes minimal side effects drives the demand for pen needles in the country.

Advancements in technology and increased healthcare spending have significantly boosted the pen needle market growth. For instance, U.S. healthcare spending increased by 4.1% to reach USD 4.5 trillion in 2022, as per the United States Centre for Medicare and Medicaid Services.

In Europe, the government is easing regulations and speeding up the approval process for innovative new drugs to meet the increasing needs of the aging population. This initiative aims to promote domestic and foreign pharmaceutical companies and attract new businesses to the European market.

In addition, increasing strategic investment by domestic market players in the form of mergers and acquisitions increases the competition, which is further expected to propel market growth opportunities in the coming years.

Furthermore, in the Asia Pacific region, increasing health awareness among the population and the rapid market evolution in using new injectable drug delivery systems or technologies are expected to drive market growth during the forecast period. The Chinese and Indian governments are establishing new policies to improve the population's health, including coverage expansion of public healthcare institutions and standardizing their services.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Pen Needle market is segmented and analyzed as follows:

By Type

  • Standard Pen Needles
  • Safety Pen Needles

By Length

  • 4mm and 5mm
  • 6mm and 8mm
  • 10mm and 12mm

By Therapy

  • Insulin
  • Glucagon-like-Peptide-1
  • Growth Hormone

By Distribution Channel

  • Online
  • Offline

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • UAE
  • Saudi Arabia
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
    • 4.1.1. Growing Demand for Packaging
    • 4.1.2. Increasing Focus on Sustainability
  • 4.2. Market Restraints
    • 4.2.1. Environmental Concerns
    • 4.2.2. High Production Cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. PEN NEEDLE MARKET ANALYSIS BY TYPE

  • 5.1. Introduction
  • 5.2. Standard Pen Needles
  • 5.3. Safety Pen Needles

6. PEN NEEDLE MARKET ANALYSIS BY LENGTH

  • 6.1. Introduction
  • 6.2. 4mm and 5mm
  • 6.3. 6mm and 8mm
  • 6.4. 10mm and 12mm

7. PEN NEEDLE MARKET ANALYSIS BY THERAPY

  • 7.1. Introduction
  • 7.2. Insulin
  • 7.3. Glucagon-like-Peptide-1
  • 7.4. Growth Hormone

8. PEN NEEDLE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Introduction
  • 8.2. Online
  • 8.3. Offline

9. PEN NEEDLE MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. United States
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. UK
    • 9.4.2. Germany
    • 9.4.3. France
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. UAE
    • 9.5.2. Saudi Arabia
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. Japan
    • 9.6.2. China
    • 9.6.3. India
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Emerging Players and Market Lucrativeness
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES

  • 11.1. Becton, Dickinson and Company
  • 11.2. Glucorx
  • 11.3. Braun Melsungen
  • 11.4. Ypsomed
  • 11.5. Novo Nordisk
  • 11.6. HTL-Strefa
  • 11.7. Ultimed, Inc.
  • 11.8. Allison Medical, Inc.
  • 11.9. Terumo Corporation
  • 11.10. Owen Mumford, Ltd.